Module | Course | Key terms |
---|---|---|
Module 1: Gender Medicine—Basics | 1.1 Gender Medicine—Basics | Sex, gender, personalized medicine, gender equality, social determinants of health |
Module 2: Gender differences in cardiology | 2.1 Cardiovascular risk factors—traditional and new! | Risk factors, pregnancy, autoimmune diseases, Mosca Score, prevention |
2.2 Heart failure diseases | Heart failure with preserved (normal) ejection fraction (HFPEF) or diastolic heart failure, Cardiomyopathies | |
2.3 Chronic ischemic heart disease | Chronic ischemic heart disease, pathophysiology | |
2.4 Acute coronary syndrome/myocardial infarction | Risk factors, non-obstructive coronary artery disease, symptoms, outcome | |
Module 3: Pulmonology | 3.1 Allergic airway diseases | Asthma, allergic airway disease, environmental factors, genetic predisposition, dyspnea |
3.2 COPD and female smokers | COPD, smoking, shortness of breath, corticosteroids, BODE index, spirometry | |
3.3 Lung cancer | Cancer, smoking, CT, estrogen receptor, fatigue | |
3.4 Sleep disturbances | Sleep, fatigue, insomnia, obstructive sleep apnea, restless legs, snoring | |
Module 4: Renal diseases | 4.1 Pathophysiology | Endocrine function, testosterone deficiency, uremic state, peritoneal sclerosis |
4.2 Clinics and diagnosis | Chronic renal disease, diabetic nephropathy, albuminuria, diabetes mellitus, polycystic kidney disease | |
4.3. End-stage renal disease | ESRD, transplantation, dialysis, age, diabetes | |
Module 5: Rheumatology | 5.1 The immune system | Autoimmunity, humoral- and cell-mediated immunity, antibodies, lymphocytes, cytokines, microchimerism |
5.2. Systemic lupus erythematosus | Autoimmune, inflammatory, renal disease, hypertension, young women, Klinefelter’s syndrome | |
5.3 Multiple sclerosis | Central nervous system, autoreactive CD4+ T cells, demyelisation, prolactin | |
5.4 Rheumatoid arthritis | Inflammation, auto-antibodies, smoking, pregnancy, Anti-TNFα medications | |
Module 6: Gastroenterology/hepatology | 6.1 Autoimmune diseases | Autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, fetal microchimerism, cirrhosis, fatigue, anorexia, amenorrhea |
6.2 Infectious diseases | Hepatitis B virus, hepatitis C virus, infection, HBsAg seroconversion, hepatocellular carcinoma, liver fibrosis, viral genotype | |
6.3 Mechanical diseases | Erosive reflux disease, non-erosive reflux disease, lower esophageal sphincter, hiatal hernias, heartburn, Barrett’s esophagus | |
6.4 Functional diseases | Abdominal pain, psychological distress, widespread gastrointestinal disorder | |
6.5 Multifactorial diseases | Ulcerative colitis, Crohn’s disease, inflammation, X chromosome, menstrual cycle, pregnancy,immunosuppression | |
Module 7: Endocrinology | 7.1 Insulin resistance and beta-cell secretion | Pre-diabetes, diabetes mell., obesity, OGTT, IGT, PCOS |
7.2 Appetite and weight gain | Obesity, lifestyle, disease, stress, puberty, adiponectin, energy metabolism, BMI | |
7.3 Bone structure and osteoporosis | Primary osteoporosis, secondary osteoporosis, osteoporotic fractures, periosteal growth, bone mineral density, menopause | |
Module 8: Neurology | 8.1 Inflammatory neurological diseases | multiple sclerosis, amyotrophic lateral sclerosis, demyelination of neurons, central nervous system, inflammation, autoreactive CD4+ T cells, autoimmune diseases, TNFalpha,interferon |
8.2 Degenerative neurological diseases | Alzheimer’s disease, Parkinson’s disease, dementia, agitation, depression, strogen, ß-amyloid plaque, brain function, dopamine, rigidity, tremor, functional disability | |
8.3 Epilepsy | Seizures, catamenial epilepsy, teratogenic effect of antiepileptic drugs | |
8.4 Stroke | Cardio-embolic, atherosclerotic and lacunar stroke, atrial fibrillation, hypertension |